Stockreport

NLS Pharmaceutics Announces Promising Preclinical Results for Parkinson's Disease Treatments [Yahoo! Finance]

NLS Pharmaceutics Ltd. - Common Shares  (NLSP) 
PDF biopharmaceutical company dedicated to pioneering therapies for rare and complex central nervous system disorders, today announced preclinical results from multiple in v [Read more]